Qualified Person Release

Qualified Person Release
Product Description

As part of our wider service offering, our QPs can release clinical batches under our MHRA IMP license or fully licensed products under a commercial manufacturer/importer’s license. Manufacturing to GMP regulations, we support QP release to clinic, market or direct to you for onward processing.
Our Qualified Person release capabilities include: We can offer QA release by Qualified Person of the clinical batch and also offer QP release of drug product to clinicWe can offer regulatory support for IMPD preparation We can complete the manufacture and subsequent release of drug product within 6 weeks of the data of manufacture

Read more Show less

Symbiosis Pharmaceutical Services LTD

  • GB
  • 2015
    On CPHI since
  • 2
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Primary activities
Contract Manufacturer
View company profile
Categories
more categories Show less

Symbiosis Pharmaceutical Services LTD

  • GB
  • 2015
    On CPHI since
  • 2
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Primary activities
Contract Manufacturer
View company profile

More Products from Symbiosis Pharmaceutical Services LTD (4)

  • Sterile Fill Finish

    Product Sterile Fill Finish

    Our facility was purpose-built to meet increasing market demand for shorter sterile drug product development timelines, while consistently maintaining regulatory compliance.
    Today, we reliably support our customers with the aseptic filling and lyophilization of conventional, biologic a...
  • Labelling & Packaging

    Product Labelling & Packaging

    We offer an efficient clinical labelling and packaging service, which allows us to manage the supply chain logistics of your project and ensure it is delivered to your chosen location. Our goal is to provide a fast and efficient service at all times.

    Once your drug product has been m...
  • Storage

    Product Storage

    To assure the quality of your medicinal product and support stability storage testing throughout your drug development programme Symbiosis offers facilities for controlled temperature and humidity storage. Operating to GMP and licensed by the MHRA we adhere to industry guidelines for recording storage temp...
  • Analytical Testing

    Product Analytical Testing

    Coordinating in-process and finished product testing with the completion of batch documentation, we can deliver your drug product within just six weeks of the date of manufacture.

    Symbiosis Pharmaceutical Services can manage all of your analytical and microbiologial testing requirements by utili...

Symbiosis Pharmaceutical Services LTD resources (3)

  • Symbiosis announces acquisition of new facility and investment in automated commercial scale GMP sterile manufacturing.

    News Symbiosis announces acquisition of new facility and investment in automated commercial scale GMP sterile manufacturing.

    Symbiosis Pharmaceutical Services Ltd. announced the purchase of new premises in Stirling, Scotland, UK. The new facility and service extension project, supported by a grant from Scottish Enterprise totalling £4.3m ($5.5m), will be implemented over a three-year period as part of a wider £26m ($34.2m) financial commitment by Symbiosis to drive the growth of the company. The growth strategy includes the addition of automated sterile manufacturing production line capabilities to extend the commercial fill/finish services that Symbiosis offers its clients.
    11 Sep 2024
  • Aseptic Manufacturing Specialists – Brochure

    Brochure Aseptic Manufacturing Specialists – Brochure

    Our purpose-built MHRA-licenced manufacturing facility has delivered over 1000 projects for clinical and small-scale commercial products. Our seasoned experts can help guide you through your next manufacturing project. The fundamental aim at Symbiosis is to meet your most demanding timelines by offering access to manufacturing slots within weeks, not months, and ensuring that your critical project is delivered on time, to the highest quality standard.
  • Symbiosis confirms commitment to growth strategy with key appointment

    News Symbiosis confirms commitment to growth strategy with key appointment

    The CMO's new Chief Operating Officer will continue the company's operational response to COVID-19.
    25 Aug 2020